|1.||Jackson, David G: 6 articles (11/2007 - 04/2002)|
|2.||Ghosh, Ilora: 4 articles (01/2014 - 12/2004)|
|3.||Datta, Kasturi: 4 articles (01/2014 - 12/2004)|
|4.||Turley, Eva A: 4 articles (08/2010 - 12/2004)|
|5.||McCarthy, James B: 3 articles (08/2010 - 12/2006)|
|6.||Hamilton, Sara R: 3 articles (08/2010 - 12/2006)|
|7.||Tolg, Cornelia: 3 articles (08/2010 - 12/2006)|
|8.||Wang, Jing: 2 articles (02/2015 - 02/2013)|
|9.||Yu, Ge: 2 articles (02/2015 - 02/2013)|
|10.||Pang, Da: 2 articles (01/2015 - 10/2009)|
08/01/2014 - "CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation."
11/16/2007 - "Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1."
07/19/2002 - "We replaced the Link module of CD44 with the homologous region of TSG-6, a hyaluronan-binding protein secreted in response to inflammation whose Link module has a higher affinity for ligand. "
01/01/1995 - "Hyaluronan receptor antagonists alter skin inflammation and fibrosis following injury."
01/01/2011 - "Plasma hyaluronan-binding protein (PHBP) is a serine protease the activation of which is implicated in inflammation. "
07/01/2004 - "In the present study, immunophenotypic expression of a novel hyaluronan receptor (LYVE-1), which is expressed by endothelial cells of normal lymphatic vessels but not blood vessels, was determined in benign and malignant vascular tumors. "
01/01/2014 - "One such hyaladherin, hyaluronan-binding protein 1 (HABP1/p32/gC1qR) has been considered to be a biomarker for tumor progression. "
02/14/2013 - "LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1) is a homolog of the hyaluronan receptor CD44, and one of the most widely used markers of lymphatic endothelial cells in normal and tumor tissues. "
02/01/2013 - "Development and validation of H11B2C2 monoclonal antibody-reactive hyaluronic acid binding protein: overexpression of HABP during human tumor progression."
03/15/2010 - "CD44 is a major cell surface hyaluronan receptor and cancer stem cell marker that has been implicated in the progression of a variety of cancer types. "
|4.||Neoplasm Metastasis (Metastasis)
02/15/2008 - "In the current study, accurate predictors for LN metastasis in patients with ECC were examined by using immunohistochemistry with the lymphatic endothelial hyaluronan receptor 1 (LYVE-1) antibody to discriminate between lymphatics and blood vessels. "
08/01/2012 - "CD44 or hyaluronan receptor is a transmembrane receptor associated with aggressive tumour growth, proliferation, and metastasis. "
06/01/2009 - "Specimens from 65 patients with invasive tumours (31 with and 34 without metastases) were evaluated for lymphatic vessel density (LVD) by the 'hot-spot' method as the density of lymphatic endothelium hyaluronan receptor (LYVE-1)-positive lymphatic vessels per unit area of tissue. "
02/01/2015 - "Hyaluronic acid binding protein 1 (HABP1/gC1qR/p32), a ubiquitous multifunctional protein belonging to the hyaladherin family, has been implicated in the tumorigenesis, progression, invasion, and metastasis of several malignant tumors. "
09/01/2012 - "Systemic blockade of the hyaluronan receptor for endocytosis prevents lymph node metastasis of prostate cancer."
06/01/2009 - "The purpose of this study was to describe CD44 antigen expression in canine mammary carcinomas and to evaluate its prognostic significance in relation to other clinico-pathological variables. "
01/01/2013 - "Over-expression of Lewis y and CD44 antigen are strong risk factors for chemotherapeutic drug resistance in ovarian carcinoma patients."
06/01/2012 - "Lac color inhibits development of rat thyroid carcinomas through targeting activation of plasma hyaluronan-binding protein."
12/01/2004 - "Differential expression of Hyaluronic Acid Binding Protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma."
07/01/2004 - "Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1)."
|1.||Hyaluronic Acid (Hyaluronan)
|2.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|3.||Biotin (Vitamin H)
|5.||Vascular Endothelial Growth Factor C
|6.||Transcription Factors (Transcription Factor)
|8.||Carrier Proteins (Binding Protein)
|10.||Ovarian epithelial cancer
|1.||Homologous Transplantation (Allograft)
|4.||Drug Therapy (Chemotherapy)